CVRx to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call on August 6, 2026
CVRx Inc CVRX
$5.18
▼ -3.81%
($-0.21)
📅 Earnings This Week
Open
$5.36
Prev Close
$5.38
Day Range
$5.03 – $5.36
52W Range
$4.37 – $11.30
Market Cap
$137.32M
Beta
0.80
EPS (TTM)
$-2.01
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-06-30 |
| Shares Out. | 26,540,000 |
| Website | cvrx.com/ ↗ |
| Phone | 17634162850 |
| Employees | 223 |
| Revenue | $14.8M |
| Gross Profit | $12.9M |
| Net Income | -$13.1M |
| Free Cash Flow | -$40.2M |
| Total Assets | $99.7M |
| Total Liabilities | $70.6M |
| Equity | $29.1M |
About CVRx Inc
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
CVRx Inc is a publicly traded company under the ticker symbol CVRX on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
13 analysts (2026-07-01)